Mostra i principali dati dell'item

dc.creatorSofou E.I., Aleksandrova S., Badulescu E., Chatzis M., Saridomichelakis M.en
dc.date.accessioned2023-01-31T09:58:33Z
dc.date.available2023-01-31T09:58:33Z
dc.date.issued2022
dc.identifier10.3390/vetsci9080385
dc.identifier.issn23067381
dc.identifier.urihttp://hdl.handle.net/11615/79160
dc.description.abstractThere is a shortage of studies reporting the efficacy of antimicrobial treatment of dogs with atopic dermatitis (AD) and skin infections (SIs). The aim of this study was to evaluate the change in the severity of skin lesions and pruritus, and the overall efficacy of antimicrobial treatment, in dogs with AD and bacterial overgrowth/infection and/or Malassezia dermatitis. A total of 20 dogs with AD and SIs were prospectively enrolled (group A) and they were examined before and after the administration of systemic antimicrobials that resulted in the resolution of SIs. In addition, 19 dogs fulfilling the same inclusion criteria and treated with systemic, with or without topical antimicrobials, were included retrospectively (group B). Since there were no major differences between the groups, their results were combined. The severity of skin lesions decreased significantly, by 30% based on Canine Atopic Dermatitis Extent and Severity Index-4 (CADESI-4), by 28.1% based on the erythema domain of CADESI-4 and based on owner’s global assessment of the severity of skin lesions. Pruritus decreased significantly, by 34.7% based on the Pruritus Visual Analogue Scale (PVAS). The efficacy of antimicrobial treatment was assessed as good to excellent by the investigator and the owner in 55% and 60% of the dogs, respectively. Despite the significant improvement, there was high variability in the response to treatment among dogs. Further studies are needed to find factors that determine the response to antimicrobial treatment in dogs with AD and SIs. © 2022 by the authors.en
dc.language.isoenen
dc.sourceVeterinary Sciencesen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85136728004&doi=10.3390%2fvetsci9080385&partnerID=40&md5=37660b6f3832a390120c94aca68a55be
dc.subjectamoxicillin plus clavulanic aciden
dc.subjectantihistaminic agenten
dc.subjectantiinfective agenten
dc.subjectcephalosporinen
dc.subjectclindamycinen
dc.subjectcyclosporineen
dc.subjectfatty aciden
dc.subjectglucocorticoiden
dc.subjecthouse dust allergenen
dc.subjectitraconazoleen
dc.subjectketoconazoleen
dc.subjectlokivetmaben
dc.subjectoclacitiniben
dc.subjectpenicillin derivativeen
dc.subjectpentoxifyllineen
dc.subjectquinoline derived antiinfective agenten
dc.subjecttacrolimusen
dc.subjectallergyen
dc.subjectanimal experimenten
dc.subjectantimicrobial therapyen
dc.subjectArticleen
dc.subjectatopic dermatitisen
dc.subjectbacterial infectionen
dc.subjectbacterial overgrowthen
dc.subjectcanine atopic dermatitis extent and severity index 4en
dc.subjectcontrolled studyen
dc.subjectDermatophagoidesen
dc.subjectdisease severity assessmenten
dc.subjectdogen
dc.subjectdrug efficacyen
dc.subjecterythemaen
dc.subjectfemaleen
dc.subjectinvestigator global assessment scaleen
dc.subjectMalasseziaen
dc.subjectMalassezia dermatitisen
dc.subjectmaleen
dc.subjectnonhumanen
dc.subjectobservational studyen
dc.subjectowner global assessment of severity scaleen
dc.subjectprospective studyen
dc.subjectpruritusen
dc.subjectpyodermaen
dc.subjectscoring systemen
dc.subjectskin defecten
dc.subjectskin infectionen
dc.subjectskin pruritusen
dc.subjectStaphylococcusen
dc.subjectstatistical analysisen
dc.subjecttopical drug administrationen
dc.subjecttreatment durationen
dc.subjecttreatment responseen
dc.subjectvisual analog scaleen
dc.subjectMDPIen
dc.titleEfficacy of Antimicrobial Treatment in Dogs with Atopic Dermatitis: An Observational Studyen
dc.typejournalArticleen


Files in questo item

FilesDimensioneFormatoMostra

Nessun files in questo item.

Questo item appare nelle seguenti collezioni

Mostra i principali dati dell'item